Conditions: Parkinson's Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 33
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if Oxaloacetate (OAA) is a safe and effective treatment for Parkinson's disease. Each subject will be asked to make 3 study visits and complete two safety follow-up phone calls over a 4 month period.

Detailed description:

Arms:
arm 1: active capsule containing 100 mg OAA and 100 mg ascorbate, taken daily arm 2: placebo capsules that contain only 100 mg ascorbate, taken daily

Interventions: intervention 1: Oxaloacetate (OAA) intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: